×
About 18,035 results

ALLMedicine™ Radical Prostatectomy Center

Research & Reviews  5,915 results

Conventional androgen deprivation therapy is associated with an increased risk of cardi...
https://doi.org/10.1371/journal.pone.0270292
PloS One; Li JR, Wang SS et. al.

Jun 29th, 2022 - Androgen Deprivation Therapy (ADT) is the mainstay treatment in advanced prostate cancer. We conducted a nationwide population-based study to evaluate the association of ADT and cardiovascular diseases. Between 2005 and 2009, patient data from the...

The impact of radical prostatectomy on the social well-being of prostate cancer survivo...
https://doi.org/10.1111/ecc.13630
European Journal of Cancer Care; Eymech O, Brunckhorst O et. al.

Jun 28th, 2022 - The impact of radical prostatectomy on the social well-being of survivors remains poorly understood. This meta-synthesis therefore aimed to integrate the findings of qualitative research evaluating the impact of surgery on the patient relationship...

Referral to radiation oncology prior to prostatectomy: Referral rates in a New Zealand ...
https://doi.org/10.1111/1754-9485.13446
Journal of Medical Imaging and Radiation Oncology; Xu-Holland AC, Kain M

Jun 26th, 2022 - Radical prostatectomy and radical radiotherapy have equivalent survival outcomes in the treatment of localised prostate cancer but differing side-effect profiles. The 2018 Faculty of Radiation Oncology of the Royal Australasian College of Radiolog...

see more →

Guidelines  8 results

Prostate Bed Delineation Guidelines for Postoperative Radiation Therapy: On Behalf Of T...
https://doi.org/10.1016/j.ijrobp.2020.11.010
International Journal of Radiation Oncology, Biology, Phy... Robin S, Jolicoeur M et. al.

Nov 14th, 2020 - Prostate bed (PB) irradiation is considered the standard postoperative treatment after radical prostatectomy (RP) for tumors with high-risk features or persistent prostate-specific antigen, or for salvage treatment in case of biological relapse. F...

The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of ...
https://doi.org/10.5858/arpa.2020-0015-RA
Archives of Pathology & Laboratory Medicine; Epstein JI, Amin MB et. al.

Jun 27th, 2020 - Controversies and uncertainty persist in prostate cancer grading. To update grading recommendations. Critical review of the literature along with pathology and clinician surveys. Percent Gleason pattern 4 (%GP4) is as follows: (1) report %GP4 in n...

ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer.
https://doi.org/10.1016/j.jacr.2018.03.019
Journal of the American College of Radiology : JACR; , Froemming AT et. al.

May 5th, 2018 - Diagnosis and management of prostate cancer post treatment is a large and complex problem, and care of these patients requires multidisciplinary involvement of imaging, medical, and surgical specialties. Imaging capabilities for evaluation of men ...

Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/...
https://doi.org/10.1200/JCO.2016.72.0466
Journal of Clinical Oncology : Official Journal of the Am... Chin J, Rumble RB et. al.

Mar 28th, 2017 - Purpose To jointly update the Cancer Care Ontario guideline on brachytherapy for patients with prostate cancer to account for new evidence. Methods An Update Panel conducted a targeted systematic literature review and identified more recent random...

Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From ...
https://doi.org/10.1016/j.jsxm.2016.11.324
The Journal of Sexual Medicine; Salonia A, Adaikan G et. al.

Mar 7th, 2017 - Sexual dysfunction is common in patients after radical prostatectomy (RP) for prostate cancer. To provide the International Consultation for Sexual Medicine (ICSM) 2015 recommendations concerning management strategies for post-RP erectile function...

see more →

Clinicaltrials.gov  732 results

Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT04808427

Jun 24th, 2022 - Background: Prostate cancer is relatively slow growing, with doubling times for local tumors estimated at 2 to 4 years. Some prostate cancers prove to be small, low grade, and noninvasive and they appear to pose little risk to the life or health o...

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT03976843

Jun 24th, 2022 - Background: About 30,000 men will die from prostate cancer in the US in 2018. The majority of these men originally presented with localized cancer. Treatment options for patients with high risk, localized disease typically involve radical prostate...

An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT04134208

Jun 24th, 2022 - PRIMARY OBJECTIVE: I. Evaluate metabolic response by fluciclovine F18 (18F-fluciclovine) PET qualitatively and semi-quantitatively with standardized uptake values (SUV) following androgen deprivation therapy (ADT) plus abiraterone at 22-28 weeks (...

Combination Immunotherapy in Biochemically Recurrent Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT03315871

Jun 24th, 2022 - Background: Androgen deprivation therapy (ADT) and surveillance are treatment options for prostate cancer patients with biochemical progression after localized therapy (i.e., biochemically recurrent [BCR] prostate cancer). The primary goal in thes...

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT03354416

Jun 24th, 2022 - Background: Multiparametric MRI (mpMRI) has become an established method for localizing clinically significant prostate cancer, and identification of imaging-based prognostic markers represents an active research area. Multiple treatments are avai...

see more →

News  555 results

A Scrotal Rash Lasting Months in a Man With Genital Edema
https://reference.medscape.com/viewarticle/851819

Jun 23rd, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

A Scrotal Rash Lasting Months in a Man With Genital Edema
https://www.medscape.com/viewarticle/851819

Jun 23rd, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Active Treatment or Observation for Localized Prostate Cancer?
https://www.medscape.com/viewarticle/975848

Jun 17th, 2022 - This study was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway Compared with observation, active treatment lowers the risk for overall and prostate cancer-specific death in men with localized prostate...

Urinating multiple times per night
https://www.mdedge.com/prostate-cancer-challenge-center/article/255032/prostate-cancer/urinating-multiple-times-night

May 27th, 2022 - On the basis of the patient's history and presentation, this is likely a case of adenocarcinoma of the prostate. Although most patients with prostate cancer are diagnosed on screening, when localized symptoms do occur, they may include urinary fre.

Urinary incontinence in transfeminine patients
https://www.mdedge.com/obgyn/article/254878/transgender-health/urinary-incontinence-transfeminine-patients
K. Ashley Brandt, DO

May 24th, 2022 - Whether your patient is a cisgender female or a transfeminine patient, urinary incontinence is unfortunately common and can have a significant negative effect on a person’s quality of life. While the incidence of incontinence is relatively well es.

see more →

Patient Education  4 results see all →